FDA recall D-847-2013

Teva Pharmaceuticals USA, Inc. · Class II · drug

Product

Methylphenidate Hydrochloride Extended-Release Capsules (LA), 20 mg, 100 count bottle, Rx only, TEVA PHARMACEUTICALS USA, NDC 0093-5346-01

Reason for recall

Failed Dissolution Specifications: Product is being recalled due to out of specification dissolution results obtained during routine stability testing.

Distribution

Nationwide

Key facts

Status
Terminated
Initiation date
2013-06-18
Report date
2013-08-14
Termination date
2014-08-27
Voluntary/Mandated
Voluntary: Firm initiated
Location
Sellersville, PA, United States

Primary source

https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-847-2013